Gene repair technology provokes biotech formation
A new biotech company has been formed to fully exploit technology for repairing genes that cause rare, hereditary diseases such as sickle cell anaemia and spinal muscular atrophy.
Archives for April 24, 2007
No need to bypass a full cardiac profile
Pharma firms can now follow US regulator's recommendations for testing the cardiac safety of drug candidates more fully - thanks to a new addition to Millipore's services.
Probiotic teams more useful than single strain - study
A combination of different probiotics strains reduces the ability of potentially pathogenic bacteria to colonise the gut more than single strains, says new research that proposes industry should look to expand research in this area.
New deals for ProBioGen's cell engineering group
ProBioGen, a specialist in mammalian cell engineering and cell culture, has entered into two separate agreements to develop therapeutic proteins with Egyptian drug manufacturer Minapharm..
Corn-based plastic heading for pharma packaging use?
A crop-based alternative to regular plastics that is biodegradeable and compostable, developed by biotechnology firm Metabolix and agriculture giant Archer Daniels Midland, is to be developed for pharmaceutical applications.
BioQuate stands firm on patent infringement suit
BioQuate has denied claims that its mainstay device for improving media throughput and maintaining sterile system integrity in biotechnology production, infringes on a patent for a rival product marketed by filtration and separation specialist Pall.
Pfizer's HIV/AIDS drug recommended for approval
After a troubling few months, Pfizer has announced some good news - US regulators have recommended its first-in-class HIV/AIDS drug should be approved.
Oral patch data means smiles all around at BDSI
A novel buccal patch formulation of the opioid painkiller fentanyl is on track to be filed for approval in the third quarter of this year, following encouraging efficacy data from a Phase III trial.
Roquette wins US patent for StarLac in novel dosage form
French company Roquette has been awarded a US patent for a dissolve-in-the-mouth drug delivery technology that makes use of its novel StarLac excipient.